Near-fatal asthma: Recognition and management

Ruben D. Restrepo, Jay I Peters

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Near-fatal asthma continues to be a significant problem despite the decline in overall asthma mortality. The purpose of this review is to discuss recent advances in our understanding of the pathophysiology, diagnosis and treatment of near-fatal asthma. RECENT FINDINGS: Two distinctive phenotypes of near-fatal asthma have been identified: one with eosinophilic inflammation associated with a gradual onset and a slow response to therapy and a second phenotype with neutrophilic inflammation that has a rapid onset and rapid response to therapy. Patients who develop sudden-onset near-fatal asthma seem to have massive allergen exposure and emotional distress. In stable condition, near-fatal asthma frequently cannot be distinguished from mild asthma. Diminished perception of dyspnea plays a relevant role in treatment delay, near-fatal events, and death in patients with severe asthma. Reduced compliance with anti-inflammatory therapy and ingestion of medications or drugs (heroin, cocaine) have been associated with fatal or near-fatal asthma. SUMMARY: Near-fatal asthma is a subtype of asthma with unique risk factors and variable presentation that requires early recognition and aggressive intervention.

Original languageEnglish (US)
Pages (from-to)13-23
Number of pages11
JournalCurrent Opinion in Pulmonary Medicine
Volume14
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Asthma
Recognition (Psychology)
Inflammation
Phenotype
Therapeutics
Heroin
Cocaine
Dyspnea
Allergens
Anti-Inflammatory Agents
Eating
Mortality
Pharmaceutical Preparations

Keywords

  • Asthma
  • Fatal asthma
  • Near-fatal asthma
  • Resistant asthma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Near-fatal asthma : Recognition and management. / Restrepo, Ruben D.; Peters, Jay I.

In: Current Opinion in Pulmonary Medicine, Vol. 14, No. 1, 01.2008, p. 13-23.

Research output: Contribution to journalArticle

@article{c5bc4edf93374fd6b497bf2f7745704d,
title = "Near-fatal asthma: Recognition and management",
abstract = "PURPOSE OF REVIEW: Near-fatal asthma continues to be a significant problem despite the decline in overall asthma mortality. The purpose of this review is to discuss recent advances in our understanding of the pathophysiology, diagnosis and treatment of near-fatal asthma. RECENT FINDINGS: Two distinctive phenotypes of near-fatal asthma have been identified: one with eosinophilic inflammation associated with a gradual onset and a slow response to therapy and a second phenotype with neutrophilic inflammation that has a rapid onset and rapid response to therapy. Patients who develop sudden-onset near-fatal asthma seem to have massive allergen exposure and emotional distress. In stable condition, near-fatal asthma frequently cannot be distinguished from mild asthma. Diminished perception of dyspnea plays a relevant role in treatment delay, near-fatal events, and death in patients with severe asthma. Reduced compliance with anti-inflammatory therapy and ingestion of medications or drugs (heroin, cocaine) have been associated with fatal or near-fatal asthma. SUMMARY: Near-fatal asthma is a subtype of asthma with unique risk factors and variable presentation that requires early recognition and aggressive intervention.",
keywords = "Asthma, Fatal asthma, Near-fatal asthma, Resistant asthma",
author = "Restrepo, {Ruben D.} and Peters, {Jay I}",
year = "2008",
month = "1",
doi = "10.1097/MCP.0b013e3282f1982d",
language = "English (US)",
volume = "14",
pages = "13--23",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Near-fatal asthma

T2 - Recognition and management

AU - Restrepo, Ruben D.

AU - Peters, Jay I

PY - 2008/1

Y1 - 2008/1

N2 - PURPOSE OF REVIEW: Near-fatal asthma continues to be a significant problem despite the decline in overall asthma mortality. The purpose of this review is to discuss recent advances in our understanding of the pathophysiology, diagnosis and treatment of near-fatal asthma. RECENT FINDINGS: Two distinctive phenotypes of near-fatal asthma have been identified: one with eosinophilic inflammation associated with a gradual onset and a slow response to therapy and a second phenotype with neutrophilic inflammation that has a rapid onset and rapid response to therapy. Patients who develop sudden-onset near-fatal asthma seem to have massive allergen exposure and emotional distress. In stable condition, near-fatal asthma frequently cannot be distinguished from mild asthma. Diminished perception of dyspnea plays a relevant role in treatment delay, near-fatal events, and death in patients with severe asthma. Reduced compliance with anti-inflammatory therapy and ingestion of medications or drugs (heroin, cocaine) have been associated with fatal or near-fatal asthma. SUMMARY: Near-fatal asthma is a subtype of asthma with unique risk factors and variable presentation that requires early recognition and aggressive intervention.

AB - PURPOSE OF REVIEW: Near-fatal asthma continues to be a significant problem despite the decline in overall asthma mortality. The purpose of this review is to discuss recent advances in our understanding of the pathophysiology, diagnosis and treatment of near-fatal asthma. RECENT FINDINGS: Two distinctive phenotypes of near-fatal asthma have been identified: one with eosinophilic inflammation associated with a gradual onset and a slow response to therapy and a second phenotype with neutrophilic inflammation that has a rapid onset and rapid response to therapy. Patients who develop sudden-onset near-fatal asthma seem to have massive allergen exposure and emotional distress. In stable condition, near-fatal asthma frequently cannot be distinguished from mild asthma. Diminished perception of dyspnea plays a relevant role in treatment delay, near-fatal events, and death in patients with severe asthma. Reduced compliance with anti-inflammatory therapy and ingestion of medications or drugs (heroin, cocaine) have been associated with fatal or near-fatal asthma. SUMMARY: Near-fatal asthma is a subtype of asthma with unique risk factors and variable presentation that requires early recognition and aggressive intervention.

KW - Asthma

KW - Fatal asthma

KW - Near-fatal asthma

KW - Resistant asthma

UR - http://www.scopus.com/inward/record.url?scp=36549033386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549033386&partnerID=8YFLogxK

U2 - 10.1097/MCP.0b013e3282f1982d

DO - 10.1097/MCP.0b013e3282f1982d

M3 - Article

C2 - 18043271

AN - SCOPUS:36549033386

VL - 14

SP - 13

EP - 23

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 1

ER -